関連する実験動画
高齢者における薬物相互作用の管理の課題
Louise Mallet1, Anne Spinewine2, Allen Huang3
1Faculty of Pharmacy, University of Montreal, Montreal, QC, Canada; Department of Pharmacy, McGill University Health Centre, Montreal, QC, Canada; McGill University, Montreal, Quebec, Canada.
Lancet (London, England)
|July 17, 2007
まとめ
高齢者の患者は,薬剤の相互作用のリスクに大きく直面しています. この研究は,総合的な高齢者アプローチを通じて,これらの相互作用を検出,管理,予防するための戦略を提案しています.
科学分野:
- ゲリアトリック・メディシン (老年医学)
- 臨床薬理学 臨床薬理学とは
背景:
- 薬物療法は高齢者の患者にとって不可欠ですが,薬物相互作用のリスクがあります.
- 高齢者の薬物相互作用の流行と文書化は十分に確立されていません.
- 薬物,病気,食品,アルコール,ハーブ製品,栄養状態の間で相互作用が起こることがあります.
研究 の 目的:
- 高齢者の薬物相互作用を分類するためのアプローチを提案する.
- 高齢者の薬物相互作用の検出,管理,予防のための戦略を概説する.
主な方法:
- 高齢患者の薬物相互作用に関する既存の知識のレビュー.
- 年齢に関連した薬理動力学および薬理動力学的変化の考慮.
- 複雑な相互作用を検出するソフトウェアの限界の評価.
主要な成果:
- 高齢者集団に関連する複数のタイプの薬物相互作用を特定しました.
- 薬物の相互作用のリスクに影響を与える要因を強調し,その中には脆弱性や心理的社会的な問題が含まれています.
- 総合的な相互作用検出における現在のソフトウェアの限界を強調した.
結論:
- 高齢者の薬物相互作用の管理には,包括的,チームベースの,高齢者のアプローチが不可欠です.
- 薬物相互作用の分類と予防のための戦略が提案されています.
- 薬物治療の最適化には,単純なソフトウェア検出を超えて全体的な評価が必要です.
関連する概念動画
Drug Dosing: Geriatric Patients
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
Pharmacodynamics in Geriatric Patients: Effects of Age
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...